Regenerative medicine

ViaCyte Announces Closing of $45 Million Financing to Advance Broadest Portfolio of Stem Cell-Derived Therapies for Type 1 Diabetes

9 days ago   |   By San Diego Biotechnology

SAN DIEGO: SAN DIEGO, June 9, 2021 /PRNewswire/ - ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced the closing of a $45 million financing tranche that brings the total Series D financing to more than $115 million. The financing includes participation by existing investors Bain Capital Life Sciences, TPG...
Read more ...

 

BioTheryX Announces First Patient Dosed with BTX-A51 in Phase 1 Clinical Trial in Patients with Advanced Solid Tumors

9 days ago   |   By San Diego Biotechnology

SAN DIEGO: SAN DIEGO, June 9, 2021 /PRNewswire/ - BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving medicines, today announced the dosing of the first patient in a dose escalation clinical trial of BTX-A51 in advanced solid tumor malignancies that are dependent upon MYC, one of...
Read more ...

 


Search by Tags

   Regenerative medicine      Therapies      Clinical      Science      Life Sciences      Medicine      Stem Cell      News      Protein  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Scientist III, Cell Biology - Chipton-Ross - San Diego, CA

Actively participate in R&D efforts to develop cutting edge viral vector-based gene delivery platforms. Actively involved in viral vector production systems for... $39 an... Read more ...

5 Steps to Get Medicare Coverage for Your IDE Clinical Trial

5 Steps to Get Medicare Coverage for Your IDE Clinical Trial

Requesting payer reimbursement for investigational device exemption clinical trials in the United States is complicated, to say the least. What's more, some medical device... Read more ...

Sweet sorghum promising for the environment

Sweet sorghum can be used to produce biogas, biofuels, and novel polymers. In addition, it can help replace phosphate fertilizers. A new sweet sorghum variety developed at... Read more ...

Psychological understanding of the term 'artificial'

Is natural always good and artificial always bad? We talked to psychologist Angela Bearth and biotechnologist Sven Panke about science, skepticism, misunderstandings and how... Read more ...

Correction to: Ectopic overexpression of a type-II DGAT derived from...

Read more ...

Two Fusarium copper radical oxidases with high activity on aryl alcohols

Biomass valorization has been suggested as a sustainable alternative to petroleum-based energy and commodities. In this context, the copper radical oxidases from Auxiliary... Read more ...

Diamonds Are a Physicist's Best Friend

Physics condensed matter experimentalist Chunhui Rita Du leverages the imperfections in diamonds to investigate materials needed for a new era of computing and storage. New... Read more ...

Chutes & Ladders-Ex-FDA chief Hahn joins Moderna backer

Chutes & Ladders-Ex-FDA chief Hahn joins Moderna backer chale Thu, 06/17/2021 - 16:22 Read more ...

Clinical verification of vimentin/EpCAM immunolipid magnetic sorting system...

Circulating tumor cells are the dominant factor leading to tumor metastasis. This study aims to investigate the effect of disparate sources of CTCs on the treatment and... Read more ...

Moderna dips into J&J's talent pool for Tal Zaks' replacement; Jim Mullen...

Paul Burton? Apparently Tal Zaks took George Costanza's concept on Seinfeld of going out on a high note to heart at Moderna, making his plans to leave his lofty perch as CMO in... Read more ...